While all the World Health Organization (WHO) regions remain committed to measles elimination, no region has achieved and sustained elimination targets of 95%.
And there have been significant decreases in measles-containing vaccine (MCV) coverage during the recent pandemic.
Among the WHO regions, the Southeast Asia Region faced the most significant decrease in first-dose MCV coverage (from 94% to 86%) between 2019 and 2021.
None of the WHO regions have recovered since 2019.
Expanding Measles Outbreaks in Many Countries
Study Looks at Extent of Residual Lung Abnormalities After COVID-19 Hospitalization
Posthospitalization prevalence of residual lung abnormalities estimated at 11.7 percent in sensitivity analyses
PTSD, Psychiatric Disorders Tied to Higher Risk for Severe COVID-19 Outcomes
Findings seen even when accounting for sociodemographic factors, comorbidities, and smoking